Beneficial function of the PD-1/PD-L1 axis blockade is confirmed in treating many different types of cancers such as non-small cell lung cancer (NSCLC), melanoma and bladder carcinoma [6,7]. Here, PDCD1 is linked to non-small cell lung carcinoma.